Advertisement
GCTK vs NUWE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCTK is a StrongBuy and NUWE is a Hold.
GCTK in upward trend: price may jump up because it broke its lower Bollinger Band on October 02, 2026
GCTK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 41 of 47 cases where GCTK's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for GCTK just turned positive on September 30, 2026. Looking at past instances where GCTK's MACD turned positive, the stock continued to rise in 37 of 47 cases over the following month. The odds of a continued upward trend are 79%.
Following a +3.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where GCTK advanced for three days, in 151 of 188 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GCTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for GCTK entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. GCTK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.348) is normal, around the industry mean (2.874). P/E Ratio (0.035) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (1.200) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GCTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Momentum Indicator for NUWE turns negative, indicating new downward trend
NUWE saw its Momentum Indicator move below the 0 level on September 28, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned negative. In 80 of the 82 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NUWE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for NUWE entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +1.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where NUWE advanced for three days, in 146 of 183 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
NUWE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.740) is normal, around the industry mean (2.874). P/E Ratio (0.000) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.007) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. NUWE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NUWE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
GCTK | NUWE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 95 | 57 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 43 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 98 | 97 | |
P/E GROWTH RATING 1..100 | 93 | 97 | |
SEASONALITY SCORE 1..100 | 90 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NUWE's Valuation (43) in the Medical Specialties industry is somewhat better than the same rating for GCTK (99) in the null industry. This means that NUWE’s stock grew somewhat faster than GCTK’s over the last 12 months.
NUWE's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as GCTK (100) in the null industry. This means that NUWE’s stock grew similarly to GCTK’s over the last 12 months.
NUWE's SMR Rating (100) in the Medical Specialties industry is in the same range as GCTK (100) in the null industry. This means that NUWE’s stock grew similarly to GCTK’s over the last 12 months.
NUWE's Price Growth Rating (97) in the Medical Specialties industry is in the same range as GCTK (98) in the null industry. This means that NUWE’s stock grew similarly to GCTK’s over the last 12 months.
GCTK's P/E Growth Rating (93) in the null industry is in the same range as NUWE (97) in the Medical Specialties industry. This means that GCTK’s stock grew similarly to NUWE’s over the last 12 months.
| GCTK | NUWE | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 81% |
| Stochastic ODDS (%) | N/A | 1 day ago 79% |
| Momentum ODDS (%) | N/A | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 79% | N/A |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Advances ODDS (%) | 16 days ago 80% | 17 days ago 80% |
| Declines ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| BollingerBands ODDS (%) | 1 day ago 87% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GCTK’s FA Score shows that 0 FA rating(s) are green while NUWE’s FA Score has 0 green FA rating(s).
- GCTK’s FA Score: 0 green, 5 red.
- NUWE’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GCTK’s TA Score shows that 3 TA indicator(s) are bullish while NUWE’s TA Score has 4 bullish TA indicator(s).
- GCTK’s TA Score: 3 bullish, 2 bearish.
- NUWE’s TA Score: 4 bullish, 3 bearish.
Price Growth
GCTK (@Medical/Nursing Services) experienced а -27.98% price change this week, while NUWE (@Medical/Nursing Services) price change was -1.58% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
Reported Earning Dates
GCTK is expected to report earnings on Nov 12, 2026.
NUWE is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
GCTK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GCTK has been loosely correlated with NUWE. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GCTK jumps, then NUWE could also see price increases.
| Ticker / NAME | Correlation To GCTK | 1D Price Change % | ||
|---|---|---|---|---|
| GCTK | 100% | -6.78% | ||
| NUWE - GCTK | 43% Loosely correlated | -8.19% | ||
| SIBN - GCTK | 31% Poorly correlated | +3.55% | ||
| QTRX - GCTK | 30% Poorly correlated | +1.79% | ||
| LAB - GCTK | 25% Poorly correlated | -2.22% | ||
| IMDX - GCTK | 24% Poorly correlated | -5.96% | ||
More | ||||
NUWE and
Correlation & Price change
A.I.dvisor indicates that over the last year, NUWE has been loosely correlated with GCTK. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NUWE jumps, then GCTK could also see price increases.
| Ticker / NAME | Correlation To NUWE | 1D Price Change % | ||
|---|---|---|---|---|
| NUWE | 100% | -8.19% | ||
| GCTK - NUWE | 43% Loosely correlated | -6.78% | ||
| NYXH - NUWE | 35% Loosely correlated | -8.16% | ||
| CVRX - NUWE | 26% Poorly correlated | N/A | ||
| CERS - NUWE | 26% Poorly correlated | -3.35% | ||
| PRE - NUWE | 24% Poorly correlated | -0.96% | ||
More | ||||